Epizyme (EPZM) Execs Share the Secret to a Successful IPO: PowerBars  
8/15/2013 7:34:59 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The IPO that set the biotech world afire hit the Nasdaq in May, but it really began way back in April 2012. Cambridge, MA-based Epizyme (NASDAQ: EPZM) had already spent five years building itself brick by brick when it faced the decision that looms for every startup biotech: whether to groom itself for a sale to Big Pharma, or chart a course for an IPO, and ultimately, independence.

Hey, check out all the research scientist jobs. Post your resume today!